← Back to Search

Stigma-Reduction Intervention for HIV Prevention

N/A

Recruiting

Led By Rodman Turpin, PhD

Research Sponsored by George Mason University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Male

18 years of age or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months post-intervention.

Awards & highlights

Study Summary

This trial aims to reduce stigma and increase PrEP use among Black queer men in MD to help protect against HIV. Participants will attend events to build community and reduce stigma.

Who is the study for?

This trial is for HIV-negative, Black sexual minority men who are 18 or older. Participants must live in Prince George's County, Maryland, or have had a sexual partner there within the past year. Those who are HIV positive or refuse HIV testing cannot join.Check my eligibility

What is being tested?

The study tests a peer-based community intervention aimed at reducing stigma and increasing support among Black queer men to encourage PrEP use for preventing HIV. It will compare those receiving the intervention with a control group to assess differences in starting and sticking with PrEP.See study design

What are the potential side effects?

Since this trial focuses on community interventions rather than medication, traditional side effects like those seen with drugs aren't expected. However, participants may experience emotional or psychological impacts from discussing sensitive topics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am male.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months post-intervention.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months post-intervention.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post-intervention. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants with a PreP prescription within one month of intervention completion.

Number of participants with a positive blood spot test for PrEP 6 months following the intervention.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

This is the arm engaging in the stigma-reduction and support-increasing activities.

Group II: ComparisonActive Control1 Intervention

This is the arm not engaging in the stigma-reduction and support-increasing activities.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

George Mason UniversityLead Sponsor

58 Previous Clinical Trials

48,674 Total Patients Enrolled

Rodman Turpin, PhDPrincipal InvestigatorGeorge Mason University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current scale of participants in this experiment?

"Affirmative. Clinicaltrials.gov attests that this clinical trial, which was first listed on March 31st 2022, is actively enrolling volunteers. The research team needs to find 120 individuals from one medical centre."

Answered by AI

Is the research team still accepting participants for this trial?

"Affirmative. Per the information available on clinicaltrials.gov, this research project is seeking participants to join and was initially posted in March of 2022 with an update made November 15th 2023. The trial requires 120 patients at a single center for enrollment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PrEP Intervention Among Black Sexual Minority Men

2022. "PrEP Intervention Among Black Sexual Minority Men". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06141408.